TRANG PHAM PHARMD
Prescription History 1255110839
Pharmacist - Ambulatory Care in Portsmouth, VA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for TRANG PHAM PHARMD, an active Ambulatory Care specialist practicing in Portsmouth, VA. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 58 documented patient claims. Among these therapy options, the most frequently utilized medication is Warfarin Sodium, which accounts for 21 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other VA PrescribersVs. VA Avg |
|---|---|---|---|
| Warfarin Sodium | 21 | $7.32▼ below VA avg | ▼ Less than typical |
About Warfarin Sodium: This medication is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and/or to prevent new clots from forming in your body. Show more ▾ Preventing harmful blood clots helps to reduce the risk of a stroke or heart attack. Conditions that increase your risk of developing blood clots include a certain type of irregular heart rhythm (atrial fibrillation), heart valve replacement, recent heart attack, and certain surgeries (such as hip/knee replacement). Warfarin is commonly called a "blood thinner," but the more correct term is "anticoagulant." It helps to keep blood flowing smoothly in your body by decreasing the amount of certain substances (clotting proteins) in your blood. An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. In 2024, this provider wrote 21 Medicare prescriptions for Warfarin Sodium, about half the volume of the typical Virginia prescriber of this medication (35.4). Medicare paid an average of $7.32 per fill, versus $8.61 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 44.8 30-Day Fills standardized to 30-day supplies 1,323 Days of Medication total across all patients in 2024 | |||
| JardianceEmpagliflozin | 14 | $839.22▼ below VA avg | ▼ Less than typical |
About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure and kidney disease. It helps to lower the risk of death from heart disease and reduces the need of going to a hospital to treat heart failure or kidney disease. It also helps to lower the risk of dialysis in people with kidney disease. Empagliflozin works by increasing the removal of sodium by your kidneys. In 2024, this provider wrote 14 Medicare prescriptions for Jardiance, about a third of the volume of the typical Virginia prescriber of this medication (47.9). Medicare paid an average of $839.22 per fill, versus $1,032.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2024 | |||
| OzempicSemaglutide | 12 | $1,323.25 | ▼ Less than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT. In 2024, this provider wrote 12 Medicare prescriptions for Ozempic, about a quarter of the volume of the typical Virginia prescriber of this medication (51.6). Medicare paid an average of $1,323.25 per fill, versus $1,312.34 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16.6 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2024 | |||
| MounjaroTirzepatide | 11 | $1,070.61▼ below VA avg | ▼ Less than typical |
About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. An analog of GASTRIC INHIBITORY POLYPEPTIDE and agonist of GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR and GLUCAGON-LIKE PEPTIDE-1 RECEPTOR used to enhance glycemic control of TYPE 2 DIABETES MELLITUS. In 2024, this provider wrote 11 Medicare prescriptions for Mounjaro, about a third of the volume of the typical Virginia prescriber of this medication (39.2). Medicare paid an average of $1,070.61 per fill, versus $1,252.39 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average VA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the VA average for this medication. 12.8 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for TRANG PHAM PHARMD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ambulatory Care prescribing approach at this Portsmouth, VA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among VA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
